Abstract
Introduction:
Suprapubic catheter (SPC) insertion is recognised as an alternative to urethral catheterisation to enable urinary drainage or continence control. This audit aims to establish the 1 and 2 year mortality associated with SPC insertion and to identify factors that may be linked with mortality.
Methods:
Data were collected for demographics, medical co-morbidities, indication for procedure and mortality from 1st February 2018 to 1st February 2020 across three NHS trusts. Multivariate regression analysis was undertaken to assess correlation between mortality and collected data.
Results:
48, 12 and 8 (total 68) SPC insertions were identified at the respective trusts. Two patients were excluded owing to a lack of mortality and cognitive data. Total mortality was 10.4% (7/67 patients) at 1 year and 16.4% (11/67 patients) at 2 years. Two-year mortality for those with a clinical frailty score (CFS) ≥3 and <3 was 21% (6/28) and 13% (5/39), p>0.05. Two-year mortality in those aged over and under 71 was 21.6% and 10.3% respectively. Other collected risk factors were not associated with increased mortality.
Conclusion:
Our study has demonstrated increased mortality rates in both the moderately to severely frail population and in elderly patients. These results have triggered the entry of SPC insertion onto the Model Hospital dashboard which states a national 1 year mortality rate of 15.4%. Clinicians should continue to be judicious when considering patients for this procedure.